Corporate Information – Page 12 – Alligator Bioscience

2022-05-09

Alligator Bioscience expands its Board of Directors with the appointment of Staffan Encrantz and Denise Goode

Lund, Sweden, May 9, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces the appointment of Staffan Encrantz and Den ...

2022-05-05

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis ...

2022-04-22

LUND (Sweden) – April 22, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Wednesda ...

2022-04-05

Regulatory

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis ...

2022-04-01

Lund, Sweden, April 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of the patient enrollment for th ...

2022-03-23

Lund, Sweden, March 23, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the ongoing OPTIMIZE-1 clinical P ...

2022-03-11

Regulatory

REGULATORY 11 March 2022 Ahead of the Annual General Meeting in Alligator Bioscience AB on May 5, 2022, the Nomination Committee announces i ...

2022-02-042022-03-23

LUND (Sweden) – February 4, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Friday ...

2022-02-01

Lund, Sweden, February 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), today announ ...